Table 2 |.
SNP | BP | EA | NEA | SJLIFE European-descent survivors not exposed to CRT (Independent dataset 1) | SJLIFE African-descent survivors not exposed to CRT (Independent dataset 2) | UK Biobank European males (Independent dataset 3) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EAFaff | EAFnon-aff | HR (95% CI) | PCOX | EAFaff | EAFnon-aff | HR (95% CI) | PCOX | EAFaff | EAFnon-aff | OR (95% CI) | PLOGISTIC | ||||||
rs112896372 | 3756587 | C | T | 0.25 | 0.18 | 1.54 (0.99–2.39) | 0.055 | 0.20 | 0.15 | 1.88 (0.60–5.88) | 0.283 | 0.18 | 0.18 | 1.0012 (0.9999–1.0024) | 0.042 | ||
rs79103129 | 3760131 | A | G | 0.25 | 0.18 | 1.53 (0.99–2.37) | 0.059 | 0.07 | 0.04 | 1.81 (0.28–11.87) | 0.536 | 0.18 | 0.18 | 1.0012 (0.9999–1.0024) | 0.039 | ||
rs4391171 | 3760305 | C | G | 0.25 | 0.18 | 1.53 (0.99–2.38) | 0.058 | 0.07 | 0.03 | 1.82 (0.28–11.87) | 0.536 | 0.18 | 0.18 | 1.0012 (0.9999–1.0024) | 0.039 | ||
rs17652293 | 3760914 | G | C | 0.25 | 0.18 | 1.53 (0.99–2.38) | 0.058 | 0.07 | 0.03 | 1.82 (0.28–11.87) | 0.536 | 0.18 | 0.18 | 1.0012 (0.9999–1.0024) | 0.040 | ||
rs35710183 | 3753773 | C | T | 0.25 | 0.18 | 1.51 (0.98–2.32) | 0.061 | 0.07 | 0.04 | 1.79 (0.27–11.77) | 0.545 | 0.18 | 0.18 | 1.0014 (0.9998–1.0025) | 0.022 |
Genomic positions are shown relative to GRCh38 (hg38); EA, effect allele; NEA, non-effect allele; EAF, effect allele frequency; EAFaff, EAF in survivors with stroke; EAFnon-aff, EAF in stroke-free survivors; HR, hazard ratio; OR, odds ratio; CI, confidence interval; PCOX, p-value from Cox regression; PLOGISTIC, p-value from logistic regression; Independent dataset 1 (60 survivors with 1581 without stroke); Independent dataset 2 (15 survivors with and 301 without stroke); Independent dataset 3 (2933 male stroke cases and 164055 male controls from the UK Biobank)